Genzyme's Synvisc-One gets US FDA nod for osteoarthritis of the knee
Saturday, February 28, 2009 16:00 IST Cambridge
Genzyme Corporation announced that the US Food and Drug Administration (FDA) has granted marketing approval for Synvisc-One (hylan G-F 20), a product intended for the relief of pain associated with osteoarthritis (OA) of the knee.
